Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Non-invasive Aesthetic Treatment Market, by End-use
1.4.2 Asia Pacific Non-invasive Aesthetic Treatment Market, by Procedure
1.4.3 Asia Pacific Non-invasive Aesthetic Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Product Launches and Product Expansions
3.2.2 Acquisition and Mergers
3.2.3 Partnerships, Collaborations and Agreements
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Sep – 2022, Feb) Leading Players
Chapter 4. Asia Pacific Non-invasive Aesthetic Treatment Market by End-use
4.1 Asia Pacific MedSpa Market by Country
4.2 Asia Pacific Hospital/Surgery Center Market by Country
4.3 Asia Pacific Traditional Spa Market by Country
4.4 Asia Pacific HCP Owned Clinic Market by Country
Chapter 5. Asia Pacific Non-invasive Aesthetic Treatment Market by Procedure
5.1 Asia Pacific Injectables Market by Country
5.2 Asia Pacific Skin Rejuvenation Market by Country
5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Non-invasive Aesthetic Treatment Market by Country
6.1 China Non-invasive Aesthetic Treatment Market
6.1.1 China Non-invasive Aesthetic Treatment Market by End-use
6.1.2 China Non-invasive Aesthetic Treatment Market by Procedure
6.2 Japan Non-invasive Aesthetic Treatment Market
6.2.1 Japan Non-invasive Aesthetic Treatment Market by End-use
6.2.2 Japan Non-invasive Aesthetic Treatment Market by Procedure
6.3 India Non-invasive Aesthetic Treatment Market
6.3.1 India Non-invasive Aesthetic Treatment Market by End-use
6.3.2 India Non-invasive Aesthetic Treatment Market by Procedure
6.4 South Korea Non-invasive Aesthetic Treatment Market
6.4.1 South Korea Non-invasive Aesthetic Treatment Market by End-use
6.4.2 South Korea Non-invasive Aesthetic Treatment Market by Procedure
6.5 Singapore Non-invasive Aesthetic Treatment Market
6.5.1 Singapore Non-invasive Aesthetic Treatment Market by End-use
6.5.2 Singapore Non-invasive Aesthetic Treatment Market by Procedure
6.6 Malaysia Non-invasive Aesthetic Treatment Market
6.6.1 Malaysia Non-invasive Aesthetic Treatment Market by End-use
6.6.2 Malaysia Non-invasive Aesthetic Treatment Market by Procedure
6.7 Rest of Asia Pacific Non-invasive Aesthetic Treatment Market
6.7.1 Rest of Asia Pacific Non-invasive Aesthetic Treatment Market by End-use
6.7.2 Rest of Asia Pacific Non-invasive Aesthetic Treatment Market by Procedure
Chapter 7. Company Profiles
7.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Approvals and Agreements:
7.1.5.3 Acquisitions and Mergers:
7.1.5.4 Partnerships, Collaborations and Agreements:
7.2 Allergan PLC (AbbVie)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisitions and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.2.5.3 Approvals and Trials:
7.3 Galderma S.A.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations and Agreements:
7.4 Merz Pharma GmbH & Co. KGaA
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Product Launches and Product Expansions:
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental &Regional Analysis
7.5.4 Research & Development Expenses
7.6 Candela Medical Corporation
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisitions and Mergers:
7.6.2.2 Partnerships, Collaborations and Agreements:
7.7 Bausch Health Companies, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Cutera, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Product Launches and Product Expansions:
7.9 Lumenis Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product Launches and Product Expansions:
7.10. Hologic, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisitions and Mergers:
7.10.5.2 Product Launches and Product Expansions:
Unique Offerings 